Evidence review / About this record
About TB-500 Reviews
Who runs this review bench, how the record is graded, and what the name does not mean.
What this site is
TB-500 Reviews runs a review bench over the published research on Thymosin Beta-4 and its Ac-LKKTETQ fragment. It reads each study the way a referee reads a submission — weighing method, sample, and strength of evidence — and grades the record accordingly, keeping the citation beside every grade. What it reviews is the literature, never a product, vendor, or batch. It sells nothing, supplies nothing, doses nothing, and books no visit; it keeps no clinical staff and gives no medical direction on any page.
How we read the record
The bench grades against primary sources. A quantitative claim earns a grade only when a specific peer-reviewed study, registered trial, or regulatory document supports it, and each reference is checkable on /references. Findings that failed to replicate are graded down and shown, not buried, and a single promising animal result is not marked up into a human conclusion. Vendor copy that conflates the synthetic fragment with full-length Tβ4 is corrected. No commercial source is linked; the bench points only to PubMed, ClinicalTrials.gov, the NIH, journals, and the agencies.
What the name does and does not claim
'Reviews' names the work — a review of the scientific record — not customer reviews, product ratings, or vendor endorsements. No seller is graded, recommended, or ranked here, and no page should be read as a buying guide. The bench takes no position on human use beyond what the literature itself supports, and it flags the difference between what is established and what is merely asserted.